Autonomix Medical (AMIX) EBIT (2022 - 2025)

Autonomix Medical (AMIX) has reported EBIT for 4 consecutive years, with -$3.3 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, EBIT fell 21.7% year-over-year to -$3.3 million in Q4 2025; TTM through Dec 2025 was -$17.6 million, a 63.23% decrease from a year earlier, with the FY2025 full-year figure at -$11.6 million, up 3.67% from the prior year.
• EBIT was -$3.3 million for Q4 2025 at Autonomix Medical, up from -$7.5 million in the prior quarter.
• Over five years, EBIT peaked at -$544000.0 in Q4 2022 and troughed at -$7.5 million in Q3 2025.
• A 4-year average of -$3.0 million and a median of -$2.8 million in 2024 frame the typical range for EBIT.
• Across the five-year window, EBIT plunged 437.5% in 2023 and surged 51.27% in 2024, its largest moves.
• Over 4 years, EBIT stood at -$544000.0 in 2022, then sank by 437.5% to -$2.9 million in 2023, then increased by 6.05% to -$2.7 million in 2024, then dropped by 21.7% to -$3.3 million in 2025.
• The last three EBIT figures came in at -$3.3 million (Q4 2025), -$7.5 million (Q3 2025), and -$3.4 million (Q2 2025), per Business Quant data.